NCM · Medical - Diagnostics & Research

ENDRA Life Sciences Inc. (NDRA) Stock

$5.46 -7.93% NCM: NDRA Healthcare

Valuation

MetricValue
Price$5.46
Market Cap$6.93M
P/E Ratio-0.96
P/B Ratio1.27
P/S Ratio0.00
EPS (TTM)$-8.93
52-Week High$9.85
52-Week Low$2.96
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-224.80%
ROA-74.50%
ROCE-92.93%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.07
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-11.0M$-13.0M$-11.0M$-11.0M$-6.0M
Net Profit$-11.0M$-13.0M$-10.0M$-12.0M$-7.0M
EPS$-5.47$-6.84$-5.89$-10.25$-8.93
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.0M$9.0M$7.0M$4.0M$4.0M
Total Liabilities$2.0M$2.0M$1.0M$2.0M$2.0M
Cash$9.0M$5.0M$3.0M$3.0M$1.0M
Borrowings$1.0M$1.0M$0$1.0M$0

Latest News

ASP Isotopes Maps Noble Africa Listing as Helium Project Nears Production MarketBeat · Jul 21, 2026 Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company Business Wire · Jul 17, 2026 ENDRA Life Sciences Gains Compliance With Nasdaq Listings Rule MT Newswires · Jul 9, 2026 Top Midday Decliners MT Newswires · Jun 25, 2026 ASP Isotopes To Merge Noble Africa With A Unit Of ENDRA – A Look At The Key Contours Of The Deal Stocktwits · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-13.0M$-10.0M$-7.0M$-5.0M
Investing Cash Flow$0$0$0$0$-3.0M
Financing Cash Flow$3.0M$0$1.0M$0$0
Net Cash Flow$2.0M$-5.0M$-2.0M$0$-2.0M
Free Cash Flow$-11.0M$-13.0M$-10.0M$-7.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.86
FCF Yield-101.88%
Quick Ratio7.10
Interest Coverage0.00
Return 1Y-30.48%
Return 3Y-99.76%
Return 5Y-99.99%

Ownership

Insiders Held8.73%
Institutions Held9.66%
Institutions Float Held10.59%
Institutional HolderSharesReport Date
Altium Capital Management, LLC51,9002026-03-31
Geode Capital Management, LLC21,0782026-03-31
Vanguard Fiduciary Trust Co10,1212026-03-31
Morgan Stanley3,5462026-03-31
Vanguard Capital Management LLC2,8162026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BBLGBone Biologics Corp $0.47 -0.43% -0.26 $845628 0.00%
BGMSBio Green Med Solution, Inc. $0.85 +3.41% -0.24 $4.69M 0.00%
BNBX $0.16 +0.00% 0.00 $210492 0.00%
DHAIDIH Holding US, Inc. $0.02 +0.00% 0.00 $41853 0.00%
GCTKGlucoTrack, Inc. $1.03 -7.21% -0.01 $822087 0.00%

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. is led by CEO Alexander Y. Tokman, employs 21 people, headquartered in US, publicly traded since 2017.

ENDRA Life Sciences Inc. (NDRA) stock trades at $5.46 with a market capitalization of $6.93M. The stock is valued at a price-to-earnings (P/E) ratio of -0.96, price-to-book of 1.27, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.96 and $9.85, and currently trades 44.6% below its 52-week high.

On profitability, ENDRA Life Sciences Inc. generates a return on equity (ROE) of -224.80%, return on capital employed of -92.93%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides